[1] Mosso L, Carvajal C, González A, et al. Primary aldosteronism and hypertensive disease[J]. Hypertension, 2003, 42: 161-165. [2] Calhoun DA. Is there an unrecognized epidemic of primary aldosteronism?(Pro)[J]. Hypertension, 2007, 50: 447-453. [3] Bardet S, Chamontin B, Douillard C, et al. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 4: Subtype diagnosis[J]. Ann Endocrinol (Paris), 2016, 77: 208-213. [4] Er LK, Lin MC, Tsai YC, et al. Association of visceral adiposity and clinical outcome among patients with aldosterone producing adenoma[J]. BMJ Open Diabetes Res Care, 2020, 8.doi: 10.1136/bmjdrc-2019-001153. [5] Uchida N, Amano N, Yamaoka Y, et al. A novel case of somatic KCNJ5 mutation in pediatric-onset aldosterone-producing adenoma[J]. J Endocr Soc, 2017, 1: 1056-1061. [6] Funder JW, Carey RM, Fardella C, et al. Case detec-tion, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guide-line[J]. J Clin Endocrinol Metab, 2008, 93: 3266-3281. [7] Allan CA, Kaltsas G, Perry L, et al. Concurrent secretion of aldosterone and cortisol from an adrenal adenoma-value of MRI in diagnosis[J]. Clin Endocrinol (Oxf), 2000, 53: 749-753. [8] Yang Y, Xiao M, Song Y, et al. H-score of 11β-hydroxylase and aldosterone synthase in the histopathological diagnosis of adrenocortical tumors[J]. Endocrine, 2019, 65: 683-691. [9] Bhatt PS, Sam AH, Meeran KM, et al. The relevance of cortisol co-secretion from aldosterone-producing adenomas[J]. Hormones (Athens), 2019, 18: 307-313. [10] Goupil R, Wolley M, Ahmed AH, et al. Does concomi-tant autonomous adrenal cortisol overproduction have the potential to confound the interpretation of adrenal venous sampling in primary aldosteronism?[J]. Clin Endocrinol (Oxf), 2015, 83: 456-461. [11] Lobo CR, Kolinioti A, Hainsworth AJ, et al. Laparos-copic adrenalectomy for co-secreting aldosterone and cortisol adenomas[J]. Int J Surg, 2012, 10: 555-559. [12] Späth M, Korovkin S, Antke C, et al. Aldosterone- and cortisol-co-secreting adrenal tumors: the lost subtype of primary aldosteronism[J]. Eur J Endocrinol, 2011, 164: 447-455. [13] Funder JW, Carey RM, Mantero F, et al. The manage-ment of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab, 2016, 101: 1889-1916. [14] Stowasser M, Tunny TJ, Klemm SA, et al. Cortisol production by aldosterone-producing adenomas in vitro[J]. Clin Exp Pharmacol Physiol, 1993, 20: 292-295. [15] Käyser SC, Dekkers T, Groenewoud HJ, et al. Study heterogeneity and estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis[J]. J Clin Endocrinol Metab, 2016, 101: 2826-2835. [16] Yamada M, Nakajima Y, Taguchi R, et al. KCNJ5 mutations in aldosterone- and cortisol-co-secreting adrenal adenomas[J]. Endocr J, 2012, 59: 735-741. [17] Åkerström T, Maharjan R, Sven Willenberg H, et al. Activating mutations in CTNNB1 in aldosterone producing adenomas[J]. Sci Rep, 2016, 6: 19546.doi: 10.1038/srep19546. |